OasisLMS

This session will review appropriate clinical indications for cardiac biomarker testing, strategies to avoid unnecessary biomarkers testing and effective quality improvement interventions to reduce unnecessary biomarker testing among hospitalized patients.

This session is presented by Christine Soong, MD, MSc and David Berg, MD, MPH. Our moderators are Lily Ackermann, MD, ScM, FHM and Ebrahim Barkoudah, MD, FACP, MPH, SFHM.

This session will focus on the current evidence for implementation strategies to promote the adoption of guideline directed medical therapy in heart failure. We will cover the gaps in care, the rationale for implementation science in this condition, recent implementation trial evidence, and a look toward the future for implementation science across cardiometabolic care.

This session is presented by Safia Chatur, MD and Ankeet Bhatt, MD, MBA, ScM. Our moderators are Lily Ackermann, MD, ScM, FHM and Ebrahim Barkoudah, MD, FACP, MPH, SFHM.

CT just flagged a tiny subsegmental PE—treat or watch? In this case-based live Q&A with experts, you will define ISSPE, recognize key imaging features, and risk-stratify patients to decide when anticoagulation is warranted and when structured surveillance is safer. We translate major guidelines into a practical protocol and interpret emerging data and trials so you finish ready to apply bedside decisions with confidence.

Bedside seconds matter—can you detect delirium before it spirals? In this rapid update, synthesize current evidence to detect early with brief screens, implement prevention bundles on rounds, prescribe only when safety demands, and manage QTc, interactions, and de-prescribing at discharge. Apply practical workflows that prevent harm and sharpen team decisions on your next shift for safer, more efficient inpatient care.